PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

The present invention discloses an immunogenic composition comprising S . pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARCELLE PAULETTE VAN MECHELEN, NATHALIE MARIE-JOSEPHE GARCON, JAN POOLMAN, PHILIPPE VINCENT HERMAND, RALPH LEON BIEMANS
Format: Patent
Sprache:eng ; por
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MARCELLE PAULETTE VAN MECHELEN
NATHALIE MARIE-JOSEPHE GARCON
JAN POOLMAN
PHILIPPE VINCENT HERMAND
RALPH LEON BIEMANS
description The present invention discloses an immunogenic composition comprising S . pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT3017827TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT3017827TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT3017827TT3</originalsourceid><addsrcrecordid>eNrjZNAN8HMN9fV39nd2dvRRCPD3iQx2dHb2cAzydHFVcPb38wp1dwxxVQgDCnr6ufIwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkviAEGMDQ3MLI_OQEGMilAAAkxcluw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE</title><source>esp@cenet</source><creator>MARCELLE PAULETTE VAN MECHELEN ; NATHALIE MARIE-JOSEPHE GARCON ; JAN POOLMAN ; PHILIPPE VINCENT HERMAND ; RALPH LEON BIEMANS</creator><creatorcontrib>MARCELLE PAULETTE VAN MECHELEN ; NATHALIE MARIE-JOSEPHE GARCON ; JAN POOLMAN ; PHILIPPE VINCENT HERMAND ; RALPH LEON BIEMANS</creatorcontrib><description>The present invention discloses an immunogenic composition comprising S . pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.</description><language>eng ; por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190128&amp;DB=EPODOC&amp;CC=PT&amp;NR=3017827T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190128&amp;DB=EPODOC&amp;CC=PT&amp;NR=3017827T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MARCELLE PAULETTE VAN MECHELEN</creatorcontrib><creatorcontrib>NATHALIE MARIE-JOSEPHE GARCON</creatorcontrib><creatorcontrib>JAN POOLMAN</creatorcontrib><creatorcontrib>PHILIPPE VINCENT HERMAND</creatorcontrib><creatorcontrib>RALPH LEON BIEMANS</creatorcontrib><title>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE</title><description>The present invention discloses an immunogenic composition comprising S . pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAN8HMN9fV39nd2dvRRCPD3iQx2dHb2cAzydHFVcPb38wp1dwxxVQgDCnr6ufIwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkviAEGMDQ3MLI_OQEGMilAAAkxcluw</recordid><startdate>20190128</startdate><enddate>20190128</enddate><creator>MARCELLE PAULETTE VAN MECHELEN</creator><creator>NATHALIE MARIE-JOSEPHE GARCON</creator><creator>JAN POOLMAN</creator><creator>PHILIPPE VINCENT HERMAND</creator><creator>RALPH LEON BIEMANS</creator><scope>EVB</scope></search><sort><creationdate>20190128</creationdate><title>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE</title><author>MARCELLE PAULETTE VAN MECHELEN ; NATHALIE MARIE-JOSEPHE GARCON ; JAN POOLMAN ; PHILIPPE VINCENT HERMAND ; RALPH LEON BIEMANS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT3017827TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MARCELLE PAULETTE VAN MECHELEN</creatorcontrib><creatorcontrib>NATHALIE MARIE-JOSEPHE GARCON</creatorcontrib><creatorcontrib>JAN POOLMAN</creatorcontrib><creatorcontrib>PHILIPPE VINCENT HERMAND</creatorcontrib><creatorcontrib>RALPH LEON BIEMANS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MARCELLE PAULETTE VAN MECHELEN</au><au>NATHALIE MARIE-JOSEPHE GARCON</au><au>JAN POOLMAN</au><au>PHILIPPE VINCENT HERMAND</au><au>RALPH LEON BIEMANS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE</title><date>2019-01-28</date><risdate>2019</risdate><abstract>The present invention discloses an immunogenic composition comprising S . pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Vaccines, methods of making vaccines and uses of the vaccines are also described.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT3017827TT
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A29%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MARCELLE%20PAULETTE%20VAN%20MECHELEN&rft.date=2019-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT3017827TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true